Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Inflammation. 2020 Aug;43(4):1436–1445. doi: 10.1007/s10753-020-01221-0

Figure 5. PAD2 inhibition decreased serum levels of NET and CitH3 in vivo.

Figure 5.

Treatment with AFM32a significantly decreased serum levels of NETs (A) and CitH3 (B) 24 h post LPS insult. DMSO: dimethyl sulfoxide; LPS: lipopolysaccharide; ds-DNA: double strand DNA. * P <0.05; ** P <0.01.